[1] |
赵春梅,孙小丽,罗喜平.阻抗控制子宫内膜切除术治疗子宫异常出血的临床应用与进展[J].中华妇幼临床医学杂志:电子版,2013,9(1):117–119.
|
[2] |
张以文.FIGO关于月经异常相关术语的共识和异常子宫出血病因的新分类系统[J].国际妇产科学杂志,2013,40(2):105–107.
|
[3] |
Munro MG,Critchley HO,Fraser IS,et al.The FIGO classification of causes of abnormal uterine bleeding in the reproductive years[J].Fertil Steril,2011,95 (7):2204–2208.
|
[4] |
Gallinat A. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients[J].J Reprod Med,2007,52(6):467–472.
|
[5] |
Kleijn JH,Engels R,Bourdrez P,et al.Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation[J]. BJOG,2008,115(2):193–198.
|
[6] |
Kalkat RK,Cartmill RS. NovaSure endometrial ablation under local anaesthesia in an outpatient setting:an observational study[J].J Obstet Gynaecol, 2011,31(2):152–155.
|
[7] |
Asgari Z,Moini A,Samiee H,et al. Endometrial ablation with the NovaSure system in Iran[J].Int J Gynaecol Obstet,2011,114(1):73–75.
|
[8] |
Baskett TF,Clough H,Scott TA.NovaSure bipolar radiofrequency endometrial ablation:report of 200 cases[J].J Obstet Gynaecol Can,2005,27(5):473–476.
|
[9] |
Cooper J,Gimpelson RJ.Summary of safety and effectiveness data from FDA:a valuable source of information on the performance of global endometrial ablation devices[J].J Reprod Med,2004,49(4):267–273.
|
[10] |
Sabbah R,Desaulniers G.Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease:12-month follow-up results of a prospective,single-arm clinical study[J].J Minim Invasive Gynecol,2006,13(5):467–471.
|
[11] |
王子静,杨永秀.诺舒阻抗控制系统子宫内膜去除术的临床应用及进展[J].国际生殖健康/计划生育杂志,2014,33(2):124–127.
|
[12] |
El-Nashar SA,Hopkins MR,Barnes SA, et al. Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders:a follow-up survey and systematic review[J].Am J Obstet Gynecol,2010,202(4):348.e1–e7.
|
[13] |
孙小丽,曾俐琴,张华明,等.诺舒阻抗控制系统治疗月经过多的临床研究[J].中华妇产科杂志,2013,48(1):55–57.
|
[14] |
Khan Z,EI-Nashar SA,Hopkins MR,et al.Efficacy and safety of global endometrial ablation after cesarean delivery:a cohort study[J].Am J Obstet Gynecol, 2011,205(5):450.el–e4.
|
[15] |
Shavell VI,Diamond MP,Senter JP,et al. Hysterectomy subsequent to endometrial ablation[J].J Minim Invasive Gynecol,2012,19(4):459–464.
|
[16] |
Penninx JP,Mol BW,Engels R,et al. Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding:a randomized controlled trial[J].Obstet Gynecol,2010,116(4):819–826.
|
[17] |
Gimpelson RJ.Ten-year literature review of global endometrial ablation with the NovaSure device[J].Int J Womens Health,2014,6:269–280.
|
[18] |
Clark TJ,Samuels N,Malick S,et al.Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office:a randomized controlled trial[J]. Obstet Gynecol,2011,117(5):1228.
|
[19] |
Daniels JP,Middleton LJ,Champaneria R,et al.Second generation endometrial ablation techniques for heavy menstrual bleeding:network meta-analysis[J]. BMJ,2012,344:e2564.
|
[20] |
Lukes AS,McBride RJ,Herring AH,et al.Improved premenstrual syndrome symptoms after NovaSure endometrial ablation[J].J Minim Invasive Gynecol,2011,18(5):607–611.
|
[21] |
ACOG Committee on Practice Bulletins-Gynecology.ACOG Practice Bulletin No.81: endometrial ablation[J].Obstet Gynecol,2007,109(5):1233–1248.
|
[22] |
Smith SE,Bacher-Lind L.Pregnancy outcomes following a NovaSure○R endometrial ablation procedure[J].J Minim Invasive Gynecol,2012,19(6):S21.
|